Funding
This work was supported by the Clementine Brigitta Maria Dalderup fund (project numbers 3021 and 3549, receiver N. van der Velde), which is an Amsterdam University fund (https://www.auf.nl/en/about-the-fund/about.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The initial B-PROOF was funded by the Netherlands Organization for Health Research and Development (ZonMw, Grant 6130.0031), the Hague; unrestricted grant from NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; NCHA (Netherlands Consortium Healthy Ageing), Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation (project KB-15-004-003), the Hague; Wageningen University, Wageningen; VUmc, Amsterdam; Erasmus Medical Center, Rotterdam; Unilever, Colworth, UK. The sponsors and patients had no role in the design or implementation of the study, data collection, data management, data analysis, data interpretation, or in the preparation, review, or approval of the manuscript.